What will happen on March 25? It’s debatable.
New session tackles controversies in dermatology.
Discourse and lively debate are at the heart of innovative learning and progress. New devices, therapies, socio-economic and political factors as well as new ways of thinking about the dermatology profession produce controversy. The 2022 Debates: Controversies in Dermatology (S017) is a new session at the AAD Annual Meeting 2022 and has been designed for interactive discussion of the issues that dermatologists will be actively encountering this year.
The questions that will be raised for debate run the gamut from clinical to professional and everything in between, including:
- What are the appropriate indications and use of oral antibiotics for acne, dupilumab for severe atopic dermatitis, PRP for hair loss?
- What are the risks and benefits of genetic expression profile testing for melanoma and skin cancer screening?
- What is the impact of current external business and political activism factors on the profession of dermatology?
The roster of expert speakers engaging in the debates include: Neal D. Bhatia, MD, FAAD; Emily Y. Chu, MD, PhD, FAAD; Brett M. Coldiron, MD, FAAD; James Q. Del Rosso, DO, FAAD; Laura K. Ferris, MD, PhD, FAAD; Roy G. Geronemus, MD, FAAD; Lynne J. Goldberg, MD, FAAD; Lawrence J. Green, MD, FAAD; Orit Markowitz, MD, FAAD; Sarah N. Robinson, MD, FAAD; Misha Rosenbach, MD, FAAD; Eric Lawrence Simpson, MD, FAAD; and Jason Bok Lee, MD, FAAD.
You can read the full debate statements and find out who will be addressing which topics by checking out the session online.
The session offers 3.00 CME credit.
Visit AAD DermWorld Meeting News Central for more articles.
